| My Account | Subscribe | Contact Us | Help |
Even drops in the bucket make a difference
It has been 22 years since Air Canada pilot Steve Steele was grounded with type 1
A traveling couple tries to stick to low carbs
Here’s something to make you sit up and take notice (maybe 100 times a night): 23 percent of type 2s have obstructive sleep apnea.
The must-have resource for physicians, educators and medical professionals who focus on the treatment of diabetes.
Finally! A fresh take on the “professional” journal. Each bi-monthly issue cuts through the jargon and presents the most important information you need to enhance your practice and assist your patients.
Each bi-monthly issue of Diabetes Health Professional is a self-contained handbook covering products, educational resources and the latest diabetes research, complimented by balanced editorial focused on medical news, drug prescription information, clinical practice recommendations and changing treatment options.
Each quarter we send you the latest, most updated research guides, product guides and educational resource guides available for you and your patients.
Each week the Diabetes Health E-Newsletter delivers links to the very latest in news, reviews, blogs and videos from Diabetes Health direct to your inbox.
As a subscriber you'll get access to the amazing Diabetes Health Digital Advantage™ so you can read the current issue of Diabetes Health magazine online wherever you are!
Latest Type 1 Issues Articles
The process of assuming a stem-like state is called “dedifferentiation.”
A study of beta cells at McGill University Health Centre in Montreal could hold significant promise for people with type 1 diabetes.
Researchers at MUHC found that pancreatic beta cells grown in vitro can return to a primitive developmental state in which they become stem-like cells. (Stem cells, adult or embryonic, are so-called “master cells” that have the ability to grow into any one of the more than 200 cell types in the human body.)
The process of assuming a stem-like state is called “dedifferentiation.” The McGill scientists found that it also works in three other types of cells found in the pancreas’s islets of Langerhans, the glands that produce insulin and other hormones.
The discovery of dedifferentiation opens the door to a next-step study of whether beta cells that have assumed stem-like characteristics can then be coaxed to regenerate into insulin producers.
Many people with type 1 diabetes retain beta cells in their pancreases despite devastating attacks on them by their own autoimmune systems. Assuming that scientists can find ways to prevent further autoimmune attacks, the ability to regenerate remnant beta cells in type 1s would be a significant advance in diabetes treatment.
Results of the MUHC study were published in the July issue of Laboratory Investigation.
1178 comments - 26 Apr 2007
147 comments - 29 Nov 2007
113 comments - 2 Apr 2008
107 comments - 13 Mar 2007
106 comments - 22 Sep 2008
Comments
Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.
When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.
For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.
Don't have your Diabetes Health Username? Register now and add your comments to all our content.
Register..
Register your Diabetes Health Username here.
Have Your Say...